Literature DB >> 14060635

THE DRUG-REQUIRING PHASE IN THE GROWTH OF DRUG-DEPENDENT ENTEROVIRUSES.

H J EGGERS, E REICH, I TAMM.   

Abstract

Keywords:  ACTINOMYCIN; COXSACKIE VIRUSES; DRUG RESISTANCE, MICROBIAL; EXPERIMENTAL LAB STUDY; GUANIDINES; KIDNEY; MONKEYS; NUCLEOSIDES; PHARMACOLOGY; RNA, VIRAL; TISSUE CULTURE; TRITIUM; VIRUS CULTIVATION

Mesh：

Substances：

Year:  1963        PMID： 14060635      PMCID： PMC221150          DOI： 10.1073/pnas.50.2.183

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  12 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production.

Authors:  D BALTIMORE; H J EGGERS; R M FRANKLIN; I TAMM
Journal:  Proc Natl Acad Sci U S A       Date:  1963-06       Impact factor: 11.205

3.  In vitro guanidino-resistance and guanidino-dependence of poliovirus.

Authors:  B LODDO; W FERRARI; A SPANEDDA; G BROTZU
Journal:  Experientia       Date:  1962-11-15

4.  Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures.

Authors:  D CROWTHER; J L MELNICK
Journal:  Virology       Date:  1961-09       Impact factor: 3.616

5.  The biosynthesis of poliovirus in cell cultures.

Authors:  J E DARNELL; H EAGLE
Journal:  Adv Virus Res       Date:  1960       Impact factor: 9.937

6.  [Inhibition of the multiplication in vitro of poliomyelitis viruses by guanidine. VII. Absence of interference of vitamins, purine and pyrimidine bases in the inhibition by guanidine].

Authors:  B LODDO
Journal:  Boll Soc Ital Biol Sper       Date:  1962-01-15

7.  2,(alpha-hydroxybenzyl)-benzimidazole (HBB) as an aid in virus classification.

Authors:  H J EGGERS; I TAMM
Journal:  Virology       Date:  1961-04       Impact factor: 3.616

8.  Antiviral effect of guanidine.

Authors:  W A RIGHTSEL; J R DICE; R J McALPINE; E A TIMM; I W McLEAN; G J DIXON; F M SCHABEL
Journal:  Science       Date:  1961-08-25       Impact factor: 47.728

9.  Guanidine conditioned infectivity of ribonucleic acid extracted from a strain of guanidine-dependent polio-1-virus.

Authors:  B LODDO; S MUNTONI; A SPANEDDA; G BROTZU; W FERRARI
Journal:  Nature       Date:  1963-01-19       Impact factor: 49.962

10.  Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole.

Authors:  H J EGGERS; I TAMM
Journal:  J Exp Med       Date:  1961-04-01       Impact factor: 14.307
View more
  7 in total

1.  CURTAILMENT OF THE LATENT PERIOD BY DOUBLE-INFECTION WITH POLIOVIRUSES.

Authors:  E WECKER; G LEDERHILGER
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  RESCUE OF DRUG-REQUIRING AND DRUG-INHIBITED ENTEROVIRUSES.

Authors:  N IKEGAMI; H J EGGERS; I TAMM
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

Review 3.  Antiviral therapy and resistance with hepatitis B virus infection.

Authors:  Hans L Tillmann
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Replication-competent picornaviruses with complete genomic RNA 3' noncoding region deletions.

Authors:  S Todd; J S Towner; D M Brown; B L Semler
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  The specific effectors of viral development.

Authors:  A Lwoff
Journal:  Biochem J       Date:  1965-08       Impact factor: 3.857

6.  Chemical approaches to selective inhibition of viral multiplication.

Authors:  I Tamm; H J Eggers
Journal:  Calif Med       Date:  1965-11

7.  Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives.

Authors:  H Shimizu; M Agoh; Y Agoh; H Yoshida; K Yoshii; T Yoneyama; A Hagiwara; T Miyamura
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.